Shares of Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $2.50.
Several research firms have commented on CRLBF. Cormark lowered shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday, November 11th. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Finally, Ventum Cap Mkts upgraded shares of Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th.
Get Our Latest Analysis on CRLBF
Cresco Labs Price Performance
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Articles
- Five stocks we like better than Cresco Labs
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tesla Investors Continue to Profit From the Trump Trade
- Why Invest in 5G? How to Invest in 5G Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.